Medicus Pharma (MDCXW) Accumulated Expenses (2023 - 2025)

Medicus Pharma has reported Accumulated Expenses for 3 years, with the latest figure at $995290.0 in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses rose 30.47% year-over-year to $995290.0; the trailing twelve-month figure through Dec 2025 stood at $995290.0 (up 30.47% YoY), and the FY2025 full-year result was $995290.0, up 30.47% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $995290.0, down from $1.6 million in the prior quarter.
• The five-year high for Accumulated Expenses was $1.8 million in Q2 2025, with the low at $404817.0 in Q4 2023.
• Historically, Accumulated Expenses has averaged $1.1 million across 3 years, with a median of $1.0 million in 2025.
• Annual changes were most pronounced in 2024 — Accumulated Expenses surged 88.44% — and 2025, when it soared 30.47%.
• Medicus Pharma's Accumulated Expenses stood at $404817.0 in 2023, then jumped by 88.44% to $762835.0 in 2024, then soared by 30.47% to $995290.0 in 2025.
• The last three Accumulated Expenses figures came in at $995290.0 (Q4 2025), $1.6 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.